Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB2538 - Provider product page

- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB2538, RRID:AB_1572542
- Product name
- CCND1 polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of CCND1.
- Storage
- Store at 4°C. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references UVA-induced cell cycle progression is mediated by a disintegrin and metalloprotease/epidermal growth factor receptor/AKT/Cyclin D1 pathways in keratinocytes.
The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini.
A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck.
He YY, Council SE, Feng L, Chignell CF
Cancer research 2008 May 15;68(10):3752-8
Cancer research 2008 May 15;68(10):3752-8
The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini.
Caldon CE, Swarbrick A, Lee CS, Sutherland RL, Musgrove EA
Cancer research 2008 Apr 15;68(8):3026-36
Cancer research 2008 Apr 15;68(8):3026-36
A genotype-phenotype examination of cyclin D1 on risk and outcome of squamous cell carcinoma of the head and neck.
Marsit CJ, Black CC, Posner MR, Kelsey KT
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Apr 15;14(8):2371-7
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Apr 15;14(8):2371-7
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image

- Experimental details
- Western blot analysis of CCND1 polyclonal antibody (Cat # PAB2538) in mouse lung tissue lysates (35 ug/lane). CCND1 (arrow) was detected using the purified polyclonal antibody.